亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017

医学 特发性肺纤维化 肺纤维化 纤维化 内科学
作者
Niranjan Jeganathan,Rory A. Smith,Matheni Sathananthan
出处
期刊:Chest [Elsevier BV]
卷期号:159 (1): 228-238 被引量:40
标识
DOI:10.1016/j.chest.2020.08.016
摘要

Background The burden of idiopathic pulmonary fibrosis (IPF)-related mortality in the United States in recent years is not well characterized. Research Question What are the trends in IPF-related mortality rates in the United States from 2004 through 2017? Study Design and Methods We used the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website, which contains data from all deceased US residents. IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in place of death and underlying cause of death. Results From 2004 through 2017, the age-adjusted mortality decreased by 4.1% in men (from 75.5 deaths/1,000,000 in 2004 to 72.4 deaths/1,000,000 in 2017) and by 13.4% in women (from 46.3 deaths/1,000,000 in 2004 to 40.1 deaths/1,000,000 in 2017). This overall decrease was driven mainly by a decline in IPF-related mortality in patients younger than 85 years. The decreasing trend also was noted in all races except White men, in whom the rate remained stable. The most common cause of death was pulmonary fibrosis. The percentage of deaths occurring in the inpatient setting and nursing homes decreased, whereas the percentage of deaths occurring at home and hospice increased. Interpretation From 2004 through 2017, the IPF age-adjusted mortality rates decreased. This may be explained partly by a decline in smoking in the United States, but further research is needed to evaluate other environmental and genetic contributors. The burden of idiopathic pulmonary fibrosis (IPF)-related mortality in the United States in recent years is not well characterized. What are the trends in IPF-related mortality rates in the United States from 2004 through 2017? We used the Multiple Cause of Death Database available through the Centers for Disease Control and Prevention website, which contains data from all deceased US residents. IPF-related deaths were identified using International Classification of Diseases, 10th revision, codes. We examined annual trends in age-adjusted mortality rates stratified by age, sex, race, and state of residence. We also evaluated trends in place of death and underlying cause of death. From 2004 through 2017, the age-adjusted mortality decreased by 4.1% in men (from 75.5 deaths/1,000,000 in 2004 to 72.4 deaths/1,000,000 in 2017) and by 13.4% in women (from 46.3 deaths/1,000,000 in 2004 to 40.1 deaths/1,000,000 in 2017). This overall decrease was driven mainly by a decline in IPF-related mortality in patients younger than 85 years. The decreasing trend also was noted in all races except White men, in whom the rate remained stable. The most common cause of death was pulmonary fibrosis. The percentage of deaths occurring in the inpatient setting and nursing homes decreased, whereas the percentage of deaths occurring at home and hospice increased. From 2004 through 2017, the IPF age-adjusted mortality rates decreased. This may be explained partly by a decline in smoking in the United States, but further research is needed to evaluate other environmental and genetic contributors. The Promise (and Pitfalls) of Administrative Data for Idiopathic Pulmonary FibrosisCHESTVol. 159Issue 1PreviewReliable and current population-based estimates of idiopathic pulmonary fibrosis (IPF) mortality are needed to better understand the epidemiologic trends of IPF. This knowledge is key to informing IPF-related health policy, patient advocacy, and future research planning. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
11秒前
英姑应助科研通管家采纳,获得10
13秒前
打打应助科研通管家采纳,获得10
13秒前
13秒前
24124f发布了新的文献求助10
16秒前
24秒前
39秒前
41秒前
大闲鱼铭一完成签到 ,获得积分10
42秒前
干净涵梅发布了新的文献求助10
47秒前
舒适的藏花完成签到 ,获得积分10
50秒前
54秒前
boogie发布了新的文献求助10
1分钟前
testmanfuxk完成签到,获得积分10
1分钟前
1分钟前
polelight发布了新的文献求助30
1分钟前
boogie完成签到,获得积分20
1分钟前
wdy111应助云缘之芒采纳,获得50
1分钟前
1分钟前
小付发布了新的文献求助10
1分钟前
1分钟前
1分钟前
红橙黄绿蓝靛紫111完成签到,获得积分10
1分钟前
cy0824完成签到 ,获得积分10
1分钟前
yyy完成签到 ,获得积分10
1分钟前
SciGPT应助科研通管家采纳,获得10
2分钟前
失眠奥特曼完成签到,获得积分10
2分钟前
2分钟前
李李发布了新的文献求助10
2分钟前
李李完成签到,获得积分20
2分钟前
刘宇童完成签到,获得积分10
2分钟前
3分钟前
Jasper应助李李采纳,获得10
3分钟前
chenting完成签到 ,获得积分10
3分钟前
小付完成签到,获得积分10
3分钟前
NexusExplorer应助科研通管家采纳,获得10
4分钟前
烟消云散完成签到,获得积分10
4分钟前
汉堡包应助梦梦采纳,获得10
4分钟前
4分钟前
Orange应助reerwt采纳,获得10
4分钟前
高分求助中
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3990049
求助须知:如何正确求助?哪些是违规求助? 3532108
关于积分的说明 11256354
捐赠科研通 3270976
什么是DOI,文献DOI怎么找? 1805166
邀请新用户注册赠送积分活动 882270
科研通“疑难数据库(出版商)”最低求助积分说明 809228